The effect of the modification treatment on the refinement of primary carbides and wear resistance of 35% Cr-4.0% C hypereutectic high chromium cast iron (HHCCI) was investigated using the ...first-principles calculations, XRD, SEM, TEM, hardness tests, and wear tests. The addition of N elements to HHCCI refined the size of the M7C3 primary carbide from 13.25 ± 0.72 μm to 11.67 ± 0.33 μm under the effect of adsorption refinement. When the compound modification elements (N + Ti + V + RE-Mg) were added, the combination of adsorption refinement and heterogeneous nucleation refinement significantly reduced the carbide size to 5.35 ± 0.15 μm. The refinement of the M7C3 primary carbide can be attributed to two components: 1) the refinement of the heterogeneous nucleation of TiC and VC. 2) the combination of N, Ti, and V with the M7C3 preferred growth surface (0001) resulting in the refinement by adsorption and reduce the size of the primary carbide. The hypereutectic high chromium cast iron after the compound modification exhibited excellent wear resistance. Under dry sliding wear condition, Compared with the unmodified sample, the wear resistance increased by 75%. Under corrosive wear conditions, the wear resistance is increased by 98.1%.
An avian-origin influenza A (H7N9) virus was a cause for concern in China in the spring of 2013. Most H7N9 infections resulted in acute respiratory distress syndrome (ARDS), which is a severe form of ...acute lung injury (ALI) that contributes to morbidity and mortality. In this study, we induced viral ALI by infecting wild-type and CCL2-deficient mice with influenza H7N9 virus. The results suggested a close association between C-C motif chemokine ligand 2 (CCL2) expressions and ALI induced by a lethal H7N9 virus strain (A/Hebei/01/2013). Elevated CCL2 levels were also detected in confirmed human cases of H7N9 and the bronchoalveolar lavage fluid (BALF) of H7N9-infected mice. Moreover, CCL2 was overexpressed in the lung tissue of infected mice. More importantly, CCL2 deficiency ameliorated H7N9-induced ALI in mice as determined by weight loss, survival rate, the wet:dry ratio of the lung, and pathology. Taken together, our findings demonstrate that CCL2 is essential for H7N9 virus infection and thus that it is a potential therapeutic target for influenza.
Human metapneumovirus (HMPV) is a common virus associated with acute respiratory distress syndrome in pediatric patients. There are no HMPV vaccines or therapeutics that have been approved for ...prevention or treatment. In this study, we constructed a novel recombinant influenza virus carrying partial HMPV fusion protein (HMPV-F), termed rFLU-HMPV/F-NS, utilizing reverse genetics, which contained (HMPV-F) in the background of NS segments of influenza virus A/PuertoRico/8/34(PR8). The morphological characteristics of rFLU-HMPV/F-NS were consistent with the wild-type flu virus. Additionally, immunofluorescence results showed that fusion proteins in the chimeric rFLU-HMPV/F-NS could work well, and the virus could be stably passaged in SPF chicken embryos. Furthermore, intranasal immunization with rFLU-HMPV/F-NS in BALB/c mice induced robust humoral, mucosal and Th1-type dominant cellular immune responses
. More importantly, we discovered that rFLU-HMPV/F-NS afforded significant protective efficacy against the wild-type HMPV and influenza virus challenge, with significantly attenuated pathological changes and reduced viral titers in the lung tissues of immunized mice. Collectively, these findings demonstrated that chimeric recombinant rFLU-HMPV/F-NS as a promising HMPV candidate vaccine has potentials for the development of HMPV vaccine.
The hybrid multibend achromat (HMBA) lattice concept is adopted in some diffraction-limited storage ring designs, which can permit relatively large on-momentum dynamic aperture and relatively weak ...sextupoles. In a typical HMBA lattice, the main arc section is constrained by the transverse phase advances making −I transformation for sextupole cancellation. In this paper, a new HMBA lattice concept with sextupole cancellation across a straight section is proposed, where −I is made between adjacent dispersion bumps of two lattice cells. This makes the main arc section free of the phase advance constraint, and as a result, the number of bending magnets (bends) in the lattice cell and the cell tunes can be easily changed, thus providing more choices for lattice design. To achieve the large phase advances required for −I in this new concept, the split bend is used as the matching bend, which is a bend split into two pieces with a quadrupole in between. The split bend also serves to reduce the emittance, and the large phase advances also give low beta functions in the straight section enhancing the insertion device brightness. Besides, for a given emittance goal, this new HMBA lattice can have fewer bends than the typical HMBA lattice due to stronger focusing in bend unit cells, which is beneficial for saving space and suppressing intrabeam scattering effect. Two lattices are given as examples to demonstrate this new concept and show its linear and nonlinear properties and further extension is also discussed.
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the coronavirus disease 2019 (COVID-19) pandemic, represents a global crisis. Most patients developed ...mild/moderate symptoms, and the status of immune system varied in acute and regulatory stages. The crosstalk between immune cells and the dynamic changes of immune cell contact is rarely described. Here, we analyzed the features of immune response of paired peripheral blood mononuclear cell (PBMC) samples from the same patients during acute and regulatory stages. Consistent with previous reports, both myeloid and T cells turned less inflammatory and less activated at recovery phase. Additionally, the communication patterns of myeloid-T cell and T-B cell are obviously changed. The crosstalk analysis reveals that typical inflammatory cytokines and several chemokines are tightly correlated with the recovery of COVID-19. Intriguingly, the signal transduction of metabolic factor insulin-like growth factor 1 (IGF1) is altered at recovery phase. Furthermore, we confirmed that the serum levels of IGF1 and several inflammatory cytokines are apparently dampened after the negative conversion of SARS-CoV-2 RNA. Thus, these results reveal several potential detection and therapeutic targets that might be used for COVID-19 recovery.
Oncolytic virotherapy is a promising strategy for the treatment of cancer. Influenza A virus has shown potential as an oncolytic agent. In this study, a recombinant PR8 influenza viral vector, called ...delNS1-GM-CSF, was generated with a partial deletion in NS and the granulocyte-macrophage colony-stimulating factor (GM-CSF) coding sequence inserted into the influenza nonstructural protein 1 gene. The morphological characteristics of delNS1-GM-CSF were examined. The delNS1-GM-CSF virus replicated well in various cell lines, including MDCK, A549, SMCC7721, and HepG2 cells. Moreover, selective cytotoxicity of the virus was observed in various hepatocellular carcinoma (HCC) cell lines, while no effect was demonstrated in the normal liver cell line LO2, as indicated by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide and crystal violet assays. Importantly, using a model based on the growth of HepG2 cells as a xenograft in nude mice, it was found that a reassortant delNS1-GM-CSF virus inhibited tumor growth significantly following intratumoral injection in a dose-dependent manner. Ex vivo results showed that the tumor inhibition efficacy of delNS1-GM-CSF was observed in HCC clinical samples. Taken together, these results are the first to demonstrate that influenza A viruses may have potential as oncolytic virotherapeutic agents against HCC.
Display omitted
•The first meta-analysis on the impact of Mediterranean diet (MD) on metabolic indicators and quality of life in cancer patients.•MD can improve the quality of life of cancer patients ...and alleviate fatigue.•MD can potentially improve the serum glucose and lipid metabolism of cancer patients, enhancing the body's antioxidant stress capacity.•MD can reduce the weight and fat mass of cancer patients.
The Mediterranean diet (MD) had a protective effect on cancer prevention. However, there has not been a systematic evaluation of the diet's comprehensive effects on metabolic indices and quality of life in cancer patients. The present meta-analysis summarizes for the first time the effects of MD on metabolic indices and quality of life in cancer patients. We conducted a randomized controlled trial (RCT) search on PubMed, Embase, and Cochrane Library, which recruited cancer patients receiving the MD intervention. Inthismeta-analysis,nine RCTswereincluded. Two authors independently extracted the data and checked the accuracy of the results. Compared with the control group, MD reduced the body weight (p < 0.00001), fat mass (p < 0.00001), % fat mass (p = 0.02), waist circumference (p < 0.00001), and BMI (p < 0.0001) of cancer patients. MD improved the scores of FICT-G (p = 0.002), Physical well-being (p < 0.00001), Emotional well-being (p < 0.00001), Functional well-being (p = 0.0002), and Fatigue (p < 0.00001). MD also increased the serum vitamin C level. Sensitivity analysis revealed that MD reduced the levels of blood glucose (p < 0.00001), triglyceride (p = 0.003), total cholesterol (p = 0.009), and LDH-C (p = 0.0002) in cancer patients. However, it did not affect the levels of HDL-C (p = 0.63) and vitamin A (p = 0.97). In brief, our findings indicate that higher MD compliance can reduce the weight and fat mass of cancer patients, improve their quality of life, and alleviate fatigue. Furthermore, MD can potentially improve cancer patients' serum glucose and lipid metabolism and enhance the body's antioxidant stress capacity. Nevertheless, further high-quality randomized controlled trials with larger sample sizes are necessary to obtain more dependable outcomes. INPLASY registration number: INPLASY 202320006.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the pandemic of coronavirus disease 2019 (COVID-19). Great international efforts have been put into the development of ...prophylactic vaccines and neutralizing antibodies. However, the knowledge about the B cell immune response induced by the SARS-CoV-2 virus is still limited. Here, we report a comprehensive characterization of the dynamics of immunoglobin heavy chain (IGH) repertoire in COVID-19 patients. By using next-generation sequencing technology, we examined the temporal changes in the landscape of the patient’s immunological status and found dramatic changes in the IGH within the patient’s immune system after the onset of COVID-19 symptoms. Although different patients have distinct immune responses to SARS-CoV-2 infection, by employing clonotype overlap, lineage expansion, and clonotype network analyses, we observed a higher clonotype overlap and substantial lineage expansion of B cell clones 2–3 weeks after the onset of illness, which is of great importance to B-cell immune responses. Meanwhile, for preferences of V gene usage during SARS-CoV-2 infection, IGHV3-74 and IGHV4-34, and IGHV4-39 in COVID-19 patients were more abundant than those of healthy controls. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic development as well as mechanistic research.